Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?8.28
 
WKN: A0Q78Q / Symbol: ALIM / Name: Alimera Sciences / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Alimera Sciences Stock

Our community is currently high on Alimera Sciences with 4 Buy predictions and 0 Sell predictions.
With a target price of 8 € there is a hugely positive potential of 94.29% for Alimera Sciences compared to the current price of 4.12 €.

Pros and Cons of Alimera Sciences in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Alimera Sciences vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Alimera Sciences - - - - - - -
Gritstone Oncology Inc -6.610% -4.678% -6.857% 6.722% 31.593% -73.850% -
Rockwell Medical Inc. 1.330% 9.901% 25.121% -6.386% -12.795% -85.658% -97.163%
Innoviva Inc. 0.700% 2.899% -0.699% 36.538% -2.740% 42.000% -

Comments

Prediction Buy
Perf. (%) -
Target price 9.226
Change
Ends at 25.03.25

Alimera Sciences, Inc. (NASDAQ: ALIM) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock.
Ratings data for ALIM provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 4.574
Change
Ends at 14.08.24

Alimera Sciences, Inc. (NASDAQ: ALIM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for ALIM provided by MarketBeat
Show more

Alimera Sciences, Inc. (NASDAQ: ALIM) was upgraded by analysts at Alliance Global Partners from a "neutral" rating to a "buy" rating.
Ratings data for ALIM provided by MarketBeat
Show more